Ratings by H.C. Wainwright (Swayampakula Ramakanth)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/4/2024 | Asensus Surgical inc. | ASXC | Downgrade | Neutral (Buy) |
0.28 (0.24) |
-14.29% | Details | |
| 4/1/2024 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2024 | Affimed Therapeutics | AFMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2024 | Delcath Systems | DCTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2024 | Pyxis Oncology Inc. | PYXS | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2024 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2024 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2024 | Ekso Bionics | EKSO | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | Elevation Oncology | ELEV | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2024 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2024 | Evaxion Biotech | EVAX | New Coverage | Buy (N/A) |
4.02 (4.12) |
2.49% | Details | |
| 1/24/2024 | Ocugen, Inc. | OCGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2024 | Ekso Bionics | EKSO | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2024 | electroCore Inc. | ECOR | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2024 | Absci Corp. | ABSI | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2024 | Harpoon Therapeutics | HARP | Downgrade | Neutral (Buy) |
10.55 (23.01) |
118.1% | Details | |
| 1/3/2024 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2023 | Quantum-SI Inc. | QSI | New Coverage | Buy (N/A) |
1.55 (1.61) |
3.87% | Details | |
| 12/8/2023 | Celcuity Inc | CELC | New Coverage | Buy (N/A) |
14.83 (15.77) |
6.34% | Details | |
| 11/30/2023 | Pyxis Oncology Inc. | PYXS | New Coverage | Buy (N/A) |
1.56 (4.30) |
175.64% | Details | |
| 11/2/2023 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2023 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2023 | Elevation Oncology | ELEV | New Coverage | Buy (N/A) |
0.68 (3.65) |
436.76% | Details | |
| 9/21/2023 | MediWound Ltd | MDWD | Maintain | Buy (N/A) |
|
Details | ||
| 9/21/2023 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2023 | Delcath Systems | DCTH | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2023 | Leap Therapeutics | LPTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | HOOKIPA Pharma Inc. | HOOK | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | MiMedx Group | MDXG | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2023 | MiMedx Group | MDXG | Maintain | Buy (N/A) |
|
Details | ||
| 6/20/2023 | Surface Oncology | SURF | Downgrade | Neutral (Buy) |
0.79 (1.07) |
35.44% | Details | |
| 6/6/2023 | Affimed Therapeutics | AFMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Codexis, Inc. | CDXS | Downgrade | Neutral (Buy) |
3.41 (2.65) |
-22.29% | Details | |
| 5/4/2023 | electroCore Inc. | ECOR | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2023 | electroCore Inc. | ECOR | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2023 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2023 | Collplant Holdings Inc. | CLGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | Delcath Systems | DCTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2023 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2023 | electroCore Inc. | ECOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | Asensus Surgical inc. | ASXC | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Ocugen, Inc. | OCGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2023 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2023 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2023 | Leap Therapeutics | LPTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | MediWound Ltd | MDWD | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2022 | Affimed Therapeutics | AFMD | New Coverage | Buy (N/A) |
2.04 (4.88) |
139.22% | Details | |
| 12/9/2022 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2022 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2022 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | MediWound Ltd | MDWD | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Verastem | VSTM | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Surface Oncology | SURF | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2022 | AVEO Pharmaceuticals | AVEO | Downgrade | Neutral (Buy) |
10.48 (15.00) |
43.13% | Details | |
| 8/30/2022 | IN8bio Inc. | INAB | New Coverage | Buy (N/A) |
1.98 (1.04) |
-47.47% | Details | |
| 8/29/2022 | Calithera Biosciences | CALA | Upgrade | Buy (Neutral) |
3.27 (0.37) |
-88.69% | Details | |
| 8/16/2022 | Diffusion Pharma | DFFN | Upgrade | Buy (Neutral) |
7.00 (4.40) |
-37.14% | Details | |
| 8/9/2022 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Surface Oncology | SURF | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | Vascular Biogenics Ltd | VBLT | Downgrade | Neutral (Buy) |
2.05 (0.16) |
-92.2% | Details | |
| 6/22/2022 | Celularity | CELU | New Coverage | Buy (N/A) |
3.78 (3.07) |
-18.78% | Details | |
| 5/13/2022 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2022 | Pulse Biosciences | PLSE | Downgrade | Neutral (Buy) |
1.48 (6.69) |
352.03% | Details | |
| 3/1/2022 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2022 | HOOKIPA Pharma Inc. | HOOK | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2022 | Pulse Biosciences | PLSE | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2021 | Vor Biopharma, Inc. | VOR | New Coverage | Buy (N/A) |
12.13 (1.70) |
-85.99% | Details | |
| 12/13/2021 | iTeos Therapeutics | ITOS | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2021 | Delcath Systems | DCTH | New Coverage | Buy (N/A) |
8.02 (5.26) |
-34.41% | Details | |
| 11/16/2021 | Pulse Biosciences | PLSE | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2021 | Calithera Biosciences | CALA | Downgrade | Neutral (Buy) |
0.86 (0.37) |
-56.98% | Details | |
| 10/18/2021 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2021 | Trillium Therapeutics | TRIL | Downgrade | Neutral (Buy) |
6.09 (18.44) |
202.79% | Details | |
| 8/16/2021 | Sesen Bio, Inc | SESN | Downgrade | Neutral (Buy) |
2.11 (0.63) |
-70.14% | Details | |
| 7/12/2021 | AVEO Pharmaceuticals | AVEO | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2021 | Janux Therapeutics | JANX | New Coverage | Buy (N/A) |
25.40 (47.10) |
85.43% | Details | |
| 6/23/2021 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2021 | Kindred Biosciences | KIN | Downgrade | Neutral (Buy) |
9.23 (9.25) |
0.22% | Details | |
| 5/5/2021 | iTeos Therapeutics | ITOS | New Coverage | Buy (N/A) |
23.03 (10.60) |
-53.97% | Details | |
| 4/1/2021 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Ocugen, Inc. | OCGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2021 | ZIOPHARM Oncology | ZIOP | Downgrade | Neutral (Buy) |
5.33 (0.87) |
-83.68% | Details | |
| 2/17/2021 | Sesen Bio, Inc | SESN | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2021 | ALX Oncology | ALXO | New Coverage | Buy (N/A) |
82.18 (16.87) |
-79.47% | Details | |
| 2/4/2021 | Ocugen, Inc. | OCGN | Upgrade | Buy (Neutral) |
2.81 (1.18) |
-58.01% | Details | |
| 1/21/2021 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2021 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2021 | Calithera Biosciences | CALA | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2020 | Surface Oncology | SURF | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2020 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2020 | Diffusion Pharma | DFFN | Downgrade | Neutral (Buy) |
0.66 (4.40) |
566.67% | Details | |
| 9/10/2020 | Trillium Therapeutics | TRIL | Upgrade | Buy (Neutral) |
13.59 (18.44) |
35.69% | Details | |
| 8/27/2020 | Personalis | PSNL | New Coverage | Buy (N/A) |
21.88 (1.25) |
-94.29% | Details | |
| 7/16/2020 | ReWalk Robotics Ltd. | RWLK | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2020 | Ekso Bionics | EKSO | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2020 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2020 | Ekso Bionics | EKSO | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2020 | Ocugen, Inc. | OCGN | Downgrade | Neutral (Buy) |
0.31 (1.18) |
280.65% | Details | |
| 6/1/2020 | AVEO Pharmaceuticals | AVEO | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2020 | Mesoblast Limited | MESO | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | Pulse Biosciences | PLSE | Upgrade | Buy (Neutral) |
11.74 (6.69) |
-43.02% | Details | |
| 4/7/2020 | Pluristem Therapeutics | PSTI | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2020 | Collplant Holdings Inc. | CLGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2020 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2020 | electroCore Inc. | ECOR | New Coverage | Buy (N/A) |
0.65 (5.65) |
769.23% | Details | |
| 3/6/2020 | Alphatec Holdings | ATEC | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2020 | Forty Seven Inc. | FTSV | Downgrade | Neutral (Buy) |
93.91 (95.51) |
1.7% | Details | |
| 2/14/2020 | Pulse Biosciences | PLSE | Downgrade | Neutral (Buy) |
12.18 (6.69) |
-45.07% | Details | |
| 2/12/2020 | IsoRay, Inc. | ISR | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2020 | Mesoblast Limited | MESO | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2020 | X4 Pharmaceuticals | XFOR | New Coverage | Buy (N/A) |
10.39 (1.13) |
-89.12% | Details | |
| 12/20/2019 | Ocugen, Inc. | OCGN | New Coverage | Buy (N/A) |
0.36 (0.31) |
-13.89% | Details | |
| 12/10/2019 | Forty Seven Inc. | FTSV | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2019 | Calithera Biosciences | CALA | New Coverage | Buy (N/A) |
3.38 (0.37) |
-89.05% | Details | |
| 11/11/2019 | Æterna Zentaris | AEZS | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2019 | Ekso Bionics | EKSO | New Coverage | Buy (N/A) |
0.59 (1.28) |
116.95% | Details | |
| 10/9/2019 | Vericel Corporation | VCEL | New Coverage | Buy (N/A) |
13.82 (45.45) |
228.87% | Details | |
| 9/17/2019 | Pluristem Therapeutics | PSTI | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2019 | Tocagen Inc. | TOCA | Downgrade | Neutral (Buy) |
4.18 (1.26) |
-69.86% | Details | |
| 9/11/2019 | AVEO Pharmaceuticals | AVEO | Upgrade | Buy (Neutral) |
0.92 (15.00) |
1530.43% | Details | |
| 9/6/2019 | Corcept Therapeutics | CORT | New Coverage | Buy (N/A) |
12.59 (22.21) |
76.41% | Details | |
| 8/19/2019 | Trillium Therapeutics | TRIL | Downgrade | Neutral (Buy) |
0.28 (18.44) |
6485.71% | Details | |
| 8/5/2019 | MediWound Ltd | MDWD | New Coverage | Buy (N/A) |
2.59 (17.66) |
581.85% | Details | |
| 6/17/2019 | ReWalk Robotics Ltd. | RWLK | Upgrade | Buy (Neutral) |
5.46 (1.05) |
-80.77% | Details | |
| 6/11/2019 | Sesen Bio, Inc | SESN | Upgrade | Buy (Neutral) |
2.32 (0.63) |
-72.84% | Details | |
| 6/5/2019 | Zomedica | ZOM | New Coverage | Buy (N/A) |
0.29 (0.13) |
-55.17% | Details | |
| 5/2/2019 | Cellectar Biosciences | CLRB | New Coverage | Buy (N/A) |
2.24 (3.02) |
34.82% | Details | |
| 3/15/2019 | ReWalk Robotics Ltd. | RWLK | New Coverage | Neutral (N/A) |
0.23 (5.46) |
2273.91% | Details | |
| 3/14/2019 | Verastem | VSTM | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2019 | Gritstone Oncology | GRTS | New Coverage | Buy (N/A) |
12.03 (0.76) |
-93.68% | Details | |
| 2/25/2019 | Pulse Biosciences | PLSE | New Coverage | Buy (N/A) |
18.23 (12.18) |
-33.19% | Details | |
| 2/1/2019 | AVEO Pharmaceuticals | AVEO | Downgrade | Neutral (Buy) |
1.77 (0.92) |
-48.02% | Details | |
| 1/31/2019 | Mesoblast Limited | MESO | New Coverage | Buy (N/A) |
4.58 (6.15) |
34.28% | Details | |
| 1/28/2019 | IsoRay, Inc. | ISR | New Coverage | Buy (Neutral) |
0.39 (0.38) |
-2.56% | Details | |
| 1/4/2019 | Sesen Bio, Inc | SESN | Downgrade | Neutral (Buy) |
1.47 (2.32) |
57.82% | Details | |
| 12/24/2018 | Histogenics Corp. | HSGX | Downgrade | Neutral (Buy) |
0.47 (0.16) |
-65.96% | Details | |
| 12/18/2018 | Advaxis | ADXS | Downgrade | Neutral (Buy) |
0.24 (0.55) |
129.17% | Details | |
| 12/18/2018 | Collplant Holdings Inc. | CLGN | New Coverage | Buy (N/A) |
4.10 (5.36) |
30.73% | Details | |
| 11/30/2018 | Forty Seven Inc. | FTSV | New Coverage | Buy (N/A) |
18.38 (95.51) |
419.64% | Details | |
| 10/15/2018 | Vascular Biogenics Ltd | VBLT | Upgrade | Buy (Neutral) |
1.43 (0.16) |
-88.81% | Details | |
| 8/17/2018 | Sesen Bio, Inc | SESN | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2018 | AVEO Pharmaceuticals | AVEO | New Coverage | Buy (N/A) |
2.32 (1.77) |
-23.71% | Details | |
| 8/13/2018 | Kindred Biosciences | KIN | Maintain | Buy (N/A) |
|
Details |
